Drug recall D-0185-2021
Product
Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, packaged as a) 100 ml (when mixed) bottle, NDC 67877-544-88; b) 200 ml (when mixed) bottle NDC 67877-544-68, Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA. Distributed by: Ascend Lab,oratories, LLC Parsippany, NJ 07054
Reason for recall
Failed Impurity/Degradation Specifications: Unidentified impurities not complying with specifications were observed in various lots of Cephalexin FOS USP 125 mg/5 mL.
Lots and codes
Lot#: a) 19144340, 19144341, Exp AUG 2021; b) 20142226, 20142227, Exp MAY 2022
Recall details
- Recalling firm
- Ascend Laboratories LLC, Parsippany, NJ
- Quantity
- 20,232 bottles
- Distribution
- Distributed Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 23, 2020
- Terminated
- June 1, 2023
Related products
- Cephalexin – drug information
- NDC 67877-544 Cephalexin · Cephalexin 125 mg/5mL · Ascend Laboratories, LLC
- NDC 67877-545 Cephalexin · Cephalexin 250 mg/5mL · Ascend Laboratories, LLC